{"disease":{"id":"localized-resectable-adult-liver-carcinoma","name":"localized resectable adult liver carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01010126","title":"Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT01395030","title":"PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Queen's Medical Center","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}